ASX Filings

Initial Director's Interest Notice

November 15, 2024

Opthea Received A$15.9 Million R&D Tax Incentive

November 15, 2024

Results of Meeting

November 15, 2024

Director Appointment/Resignation

November 15, 2024

Chair's Address to Shareholders

November 15, 2024

Opthea's Wet AMD Program Featured at Ophthalmology Events

November 12, 2024

Update Opthea Participates in November Investor Conferences

November 4, 2024

Opthea to Participate in November Investor Conferences

November 4, 2024

Quarterly Activities/Appendix 4C Cash Flow Report

October 31, 2024

Opthea Corporate Presentation - Oct 2024

October 28, 2024